Acquirer
Boston Scientific
Boston Scientific appears as the named buyer in 14 recorded transactions between 2015 and 2023, most often in healthcare & life sciences. 1 of those was bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Boston Scientific has bought
Every recorded transaction where Boston Scientific is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Relievant Medsystems | Healthcare & Life Sciences | — | 2023-09-18 | $850m |
| Apollo Endosurgery | Healthcare & Life Sciences | — | 2022-11-29 | $615m |
| Vertiflex | Healthcare & Life Sciences | — | 2019-05-09 | $465m |
| Augmenix | Healthcare & Life Sciences | — | 2018-09-06 | $500m |
| VENITI | Healthcare & Life Sciences | Baird Capital Partners Europe PE | 2018-08-08 | $160m |
| Claret Medical | Healthcare & Life Sciences | — | 2018-07-20 | $220m |
| Cryterion Medical | Healthcare & Life Sciences | — | 2018-07-05 | $202m |
| nVision Medical Corp. | Healthcare & Life Sciences | — | 2018-04-16 | $150m |
| NxThera | Healthcare & Life Sciences | — | 2018-03-21 | $306m |
| Apama Medical | Healthcare & Life Sciences | Shifamed LLC | 2017-10-02 | $175m |
| Symetis SA | Healthcare & Life Sciences | — | 2017-03-30 | $435m |
| EndoChoice Holdings | Healthcare & Life Sciences | — | 2016-09-27 | $210m |
| CeloNova Biosciences - Interventional Radiology Business | Healthcare & Life Sciences | Alta Biomaterials | 2015-11-10 | $70m |
| Xlumena | Healthcare & Life Sciences | — | 2015-04-01 | $63m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.